由于用于肥胖症管理的GLP-1药物使用增加,产科手术减少了25%。 25% decline in bariatric surgeries due to increased GLP-1 drug use for obesity management.

使用GLP-1药物管理肥胖症的情况激增,导致美国儿科手术减少25%。 The use of GLP-1 drugs for obesity management has surged, leading to a 25% decline in bariatric surgeries in the U.S. 这些药物有效调节胃口和控制血糖,提供了除外科手术以外的非侵入性替代药物。 These medications, effective in appetite regulation and blood sugar control, offer a non-invasive alternative to surgery. 病人越来越喜欢GLP-1药物,因为其风险和副作用较低。 Patients increasingly prefer GLP-1 drugs for their lower risks and side effects. 这一趋势表明保健行业内肥胖症治疗方法发生了显著变化。 This trend signifies a notable shift in obesity treatment approaches within the healthcare industry.